** Shares in Australia's Mayne Pharma MYX.AX gain as much as 14.8% to A$6.5; hitting their highest since February 21
** A court ruling on Wednesday stopped drugmaker Cosette from abandoning its A$672 million ($437.61 million) takeover of Mayne
** Mayne will be taking all steps within its scope to implement the deal
** Cosette has been trying to terminate the offer, after saying it was reviewing the deal because of a "material adverse change" in Mayne's performance
** Mayne stock marks biggest intraday percentage gain since mid-May
** Stock up 26.8% YTD
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com))